MedDataX Logo

Vending Machine Naloxone Distribution for Your Community (VENDY)

NCT ID: NCT06429436

Last Updated: 2025-11-13

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

PHASE4

Total Enrollment

4000 participants

Study Classification

INTERVENTIONAL

Study Start Date

2024-06-01

Study Completion Date

2026-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Vending machines are an innovative strategy shown to increase access to naloxone, a medication used to reverse opioid overdose. The aim of this proposal is to study the reach of a community-initiated, stakeholder engaged adaptation of naloxone distribution, VEnding machine Naloxone Distribution for Your community (VENDY) program.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This pilot assessment of the VENDY program will take place in 3 communities. Each community will have a machine (vending or kiosks) in which naloxone will be distributed for free to community members. Our preliminary work identified the locations desired by community members who use illegal drugs for machine placement. The pilot test test will include evaluation of the reach (naloxone distribution), adoption (% of sites and staff implementing), and implementation (fidelity to restocking and maintenance protocol) of VENDY in each community.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Harm Reduction Naloxone Opioid Overdose

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

We will be using an interrupted time series design to evaluate naloxone distribution before and after vending machine implementation in each community.
Primary Study Purpose

HEALTH_SERVICES_RESEARCH

Blinding Strategy

NONE

There will be no masking.

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

VENDY

Each participating site will install at least 1 machine (vending or kiosks) in the respective community for naloxone distribution.

Group Type EXPERIMENTAL

VENDY

Intervention Type BEHAVIORAL

At least 1 machine (vending machine like a snack machine or a machine like a newspaper kiosk) will be placed in the respective community served by the participating organizations. Any person in the community can get naloxone from the machine. The vending machine will require a code that will be placed on the machine for anyone to use. The kiosks are a box that you simply pull open and naloxone can be obtained. Naloxone kits will be provided for free as part of the current naloxone distribution program within each respective organization.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

VENDY

At least 1 machine (vending machine like a snack machine or a machine like a newspaper kiosk) will be placed in the respective community served by the participating organizations. Any person in the community can get naloxone from the machine. The vending machine will require a code that will be placed on the machine for anyone to use. The kiosks are a box that you simply pull open and naloxone can be obtained. Naloxone kits will be provided for free as part of the current naloxone distribution program within each respective organization.

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Any person in the community who desires to obtain naloxone will be able to use the machines

Exclusion Criteria

* Inability to enter a code on a vending machine or open a kiosk.
Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Southern Colorado Harm Reduction Association

UNKNOWN

Sponsor Role collaborator

Denver Health and Hospital Authority

OTHER

Sponsor Role collaborator

Summit County Public Health

UNKNOWN

Sponsor Role collaborator

University of Colorado, Denver

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Nicole Wagner, PhD

Role: PRINCIPAL_INVESTIGATOR

University of Colorado, Denver

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Denver Health

Denver, Colorado, United States

Site Status RECRUITING

Summit County Public Health Department

Frisco, Colorado, United States

Site Status RECRUITING

Southern Colorado Harm Reduction Association

Pueblo, Colorado, United States

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

United States

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Nicole Wagner, PhD

Role: CONTACT

Phone: (303)724-7095

Email: [email protected]

Meagan R Bean, MPH

Role: CONTACT

Phone: (303)724-7095

Email: [email protected]

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

22-0546

Identifier Type: -

Identifier Source: org_study_id